Corneal Implants Market Analysis

Corneal Implants Market Analysis

Corneal implants market from human donor tissue segment recorded a valuation of over USD 320 million in 2021. The segmental gains can be attributed to the rising awareness about corneal transplantation and eye tissue donation techniques. The extensive usage of non-optical grade corneas for therapeutic purposes has resulted in an upsurge in the utilization of donor corneas. Hence, taking note of these scenarios, the industry is set to register a lucrative growth.

To get key market trends

  Download Free Sample

Corneal implants market from anterior lamellar keratoplasty (ALK) segment is predicted to depict over 7.5% CAGR through 2030. The increasing prevalence of several eye diseases and the subsequent surge in the number of anterior lamellar keratoplasty procedures are the major factors positively influencing segment expansion. The rising popularity of minimally invasive procedures, coupled with the fewer postoperative and intraoperative complications associated with the transplant technique, will increase segment share.

Corneal implants market from keratoconus segment is predicted to reach USD 150 million by 2030. Keratoconus is a common eye disease that affects the structure of the cornea and often results in loss of vision. The increased cognizance of corneal transplantation as an effective procedure to restore sight in those with the given condition will accelerate business trends. The inability of keratoconic corneas to handle ultraviolet light-induced oxidative stress and the expanding aging population may further propel the market size.

The hospitals segment is set to surpass USD 245 million by 2030. Hospital settings have the availability of robust healthcare infrastructure, emergency facilities, and skilled healthcare professionals, ensuring better patient outcomes. The presence of advanced medical equipment across these establishments translates into an increasing number of patient footfalls, thus augmenting the industry landscape.

North America corneal implants market was worth over USD 190 million in 2021. This is credited to the expanding geriatric population base and the greater susceptibility of aging people to several chronic ailments, such as diabetes. Diabetic people are more prone to developing eye diseases that lead to vision loss. National Eye Institute estimates suggest that over 30,000 Americans undergo corneal transplants to replace injured and diseased corneas, creating numerous growth opportunities for the regional industry.